ABSTRACT
OBJECTIVE: Myocardial infarction (MI) is one of the most important causes of death. MI-related tissue loss and cardiac remodeling may result in heart failure. Intramyocardial injection of mesenchymal stem cells derived from adipose tissues, in acute MI animal models, has shown promising regenerative capabilities. This study aimed to investigate the myocardial regenerative capacity of epicardial adipose tissue-derived mesenchymal stem cells (ADSCs) in a rabbit model of MI. MATERIALS AND METHODS: A rabbit model of MI was performed in three groups: a sham-operated group, a control group, and a treatment group. MI was induced by coronary artery ligation via thoracotomy in the first operation. Four weeks after the first operation, intramyocardial injections of phosphate-buffered saline (PBS; control group) or ADSCs (10×106 in 100 µL; treatment group) were performed in the peri-infarct zone. Four weeks after the second operation, rabbits were sacrificed for further analysis. RESULTS: A significant increase in ejection fraction (p<0.0001) was detected in the treatment group, along with a significant increase in vascular density (p<0.001) and a significant decrease in infarct size (p<0.05) compared to the control group. CONCLUSIONS: Epicardial adipose tissue is a rich source of mesenchymal stem cells, which can differentiate into cardiomyocytes, as well as having neoangiogenic properties. Due to its potential to ameliorate chronic ischemic changes in the heart, it may be preferable in cardiac regenerative cell therapies.
Subject(s)
Adipose Tissue/cytology , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/cytology , Myocardial Infarction/therapy , Ventricular Remodeling , Animals , Myocardial Infarction/pathology , RabbitsABSTRACT
OBJECTIVE: The effect of vitamin D and renin-angiotensin-aldosterone system blockade medications in pathophysiology of contrast induced nephropathy (CIN) is controversial. The effects of paricalcitol (active vitamin D analogue) and losartan treatments in an experimental model of CIN were investigated in this study. MATERIALS AND METHODS: Thirty-six male Wistar albino rats were examined in five treatment groups. Placebo group (Group A; n = 4) received no active medication; control group (Group B; n = 8) received only contrast media (CM); Group C (n = 8) received paricalcitol; Group D (n = 8) received losartan and Group E (n = 8) received paricalcitol plus losartan. CIN was induced by NG-nitro-L-arginine methyl ester and indomethacin before iohexol injection. Renal histopathological findings were categorized and renal immunohistochemical examinations by caspase-3 rabbit primary antibody were performed. RESULTS: Creatinine and cystatin C levels significantly increased in the treatment groups, compared to Group A. However, creatinine levels were not significantly increased in Groups C, D and E compared to Group B. Compared to Group B, a significant increase of cystatin C levels was observed in Group D (p < 0.01). In Group E, when paricalcitol treatment was added to losartan treatment, cystatin C levels were similar to Group B (p = 1.00). In histopathological and immunohistochemical examination frequency of Grade 2/3 tubular necrosis and renal caspase 3 activity scores were significantly higher in the losartan treatment group compared to the other treatment groups. The histopathological effects related to losartan treatment were found to be reversed when paricalcitol treatment was combined. CONCLUSIONS: Our findings suggest that paricalcitol treatment counteracts increased contrast induced nephropathy caused by losartan. These findings warrant further clinical studies to investigate the benefit of paricalcitol in CIN prophylaxis.
Subject(s)
Contrast Media/toxicity , Disease Models, Animal , Ergocalciferols/administration & dosage , Kidney Diseases/chemically induced , Kidney Diseases/drug therapy , Renin-Angiotensin System/drug effects , Animals , Drug Therapy, Combination , Kidney Diseases/pathology , Losartan/administration & dosage , Male , Rabbits , Rats , Rats, Wistar , Renin-Angiotensin System/physiologyABSTRACT
OBJECTIVE: The SYNTAX Score was recently developed to characterize the coronary vasculature with respect to the number of lesion's location, complexity, and functional impact and it is a quantitative scoring system to assist with patient selection for optimal revascularization strategy between percutaneous coronary intervention (PCI) and coronary artery by-pass surgery (CABG). b2-glycoprotein I (b2GPI), a plasma protein that binds cardiolipin, acts as a modulator of platelet aggregation and coagulation. Antibodies to b2GPI may have a role in atherosclerosis by inducing endothelial cell activation. We investigated the relationship between anti beta 2 GPI and severity of coronary artery stenosis by calculating the SYNTAX Score among patients undergoing CABG surgery. PATIENTS AND METHODS: We prospectively investigate 612 patients who undergo elective coronary angiography between September 2012 and June 2013. Patients were evaluated for blood chemistry and anti-b2GPI IgA, IgM and IgG. Ninety seven patients with complete biochemical analysis including anti Beta 2 GPI antibodies and undergone CABG have been enrolled in this study. We divided patients in to 2 groups according to the SYNTAX scores. Group 1 included 48 patients with low SYNTAX scores (<23) and group 2 included 49 patients with intermediate and high SYNTAX scores (>23). RESULTS: There was significant correlation between elevated anti b2GPI IgG levels and higher SYNTAX score which indicate advanced and complex CAD. In this study, lesion complexity increased progressively with increasing anti-b2GPI-IgG type of antibody levels. According to this findings, anti-b2GPI-IgG is a strong predictor of higher SYNTAX score. CONCLUSIONS: In addition to the traditional risk factors for atherosclerosis, the proinflammatory and procoagulant activities of antiphospholipid antibodies appear to be important risk factors for atherosclerotic occlusive disease.
Subject(s)
Coronary Artery Bypass/methods , Coronary Artery Disease/immunology , Coronary Artery Disease/surgery , Immunoglobulin G/blood , Risk Assessment/methods , beta 2-Glycoprotein I/immunology , Angioplasty, Balloon, Coronary , Atherosclerosis/immunology , Atherosclerosis/pathology , Coronary Artery Disease/blood , Coronary Artery Disease/pathology , Coronary Stenosis/immunology , Coronary Stenosis/pathology , Coronary Vessels/pathology , Female , Humans , Immunoglobulin G/immunology , Male , Middle Aged , Risk Factors , Severity of Illness IndexABSTRACT
AIM: Chemotherapy-induced nausea and vomiting (CINV) is not understood completely. The aim of this study is to investigate the effects of smoking on CINV. METHODS: 121 consecutive patients who received cisplatin (≥ 50 mg/m²) based chemotherapy were included in the study. The patients who reported motion sickness, pain, emesis during past pregnancy, emesis history of previous chemotherapy, with Karnofsky score < 70, peptic ulcer, gastroesophageal reflux, migraine, central nervous system metastasis and patients scheduled to receive radiation therapy were excluded from the study. A standard antiemetic treatment was given to all patients. The nausea and vomiting was assessed by the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire. After first cycle of chemotherapy, Grade 2 - 3 nausea and vomiting were questioned. RESULTS: Grade 2 - 3 nausea and vomiting was higher in non-smokers (p < 0.001). We found that nausea and vomiting in women is more frequent than in men (p < 0.001). CONCLUSION: In our study we found that smokers had a lower incidence of CINV. Further investigations are needed to confirm the findings of this pilot study.
Subject(s)
Antineoplastic Agents/adverse effects , Nausea/chemically induced , Smoking , Vomiting/chemically induced , Adult , Aged , Female , Humans , Male , Middle Aged , Nausea/prevention & control , Prospective Studies , Vomiting/prevention & controlABSTRACT
A continuously operated, intermittently fed reactor (fermenter) system with a 2-d solids retention time was proposed for supporting biological nutrient removal from liquid dairy manure. The first objective of this study was to select a material with high fermentation potential to be used as the fermenter feed. Primary sludge, liquid separated dairy manure, and flushed dairy manure were investigated for their fermentation potential. Liquid separated dairy manure had the highest fermentation potential, 0.73mg volatile fatty acid as chemical oxygen demand/mg of initial volatile suspended solids (VSS). The second objective was to investigate the performance of a pilot-scale fermenter operated under an average organic loading rate (OLR) of 3 kg-VSS/m(3)/d. The reactor utilized 18% of the manure fermentation potential. Performance comparison of the pilot-scale fermenter and a lab-scale fermenter with an average OLR of 7 kg-VSS/m(3)/d highlighted the need to increase the OLR of the pilot-scale fermenter so that it can exploit a higher fraction of the manure fermentation potential. A continuously operated, intermittently fed fermenter with 2-d SRT can utilize the majority of the manure fermentation potential and support a downstream BNR reactor provided that it receives a sufficiently high OLR.